A conservative report that reads well! My unlicenced advice to most holders would be to read it carefully a few times prior to form judgement.
From the RM Research report get a clearer picture of the future CDY road map, pipeline time frames and overall positioning. Unlike many other biotechs with blue sky therapeutic pipelines, much of the funding here will clearly come from the (also blue sky) potential of the diagnostics.
cheers
- Forums
- ASX - By Stock
- AN1
- new research link
new research link , page-6
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable